BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AbbVie 



      U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.


 Key Statistics


Email:
Ownership: Public

Web Site: AbbVie
Employees:
Symbol: ABBV
 



Industry
Pharmaceutical






 Company News
AbbVie (ABBV) Nabs Positive CHMP Opinions For VIEKIRAX Plus EXVIERA To Treat HCV 11/21/2014 7:20:39 AM
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014 5:50:39 AM
Paulson Opens New Stake In AbbVie (ABBV), Nearly Triples Shire Shares 11/18/2014 7:43:15 AM
AbbVie (ABBV)To Present Data On Investigational Oncology Compounds At The 56th American Society of Hematology Annual Meeting 11/17/2014 12:19:41 PM
AbbVie (ABBV) To Present At Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014 11:45:50 AM
AbbVie (ABBV) Presents Results From Study Of ABT-414 In Patients With Glioblastoma Multiforme At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology 11/17/2014 10:27:38 AM
Ablynx (ABLYF) To Present Data On Its Anti-Il-6r Nanobody, Developed In Partnership With AbbVie (ABBV), At The American College of Rheumatology Annual Meeting 11/14/2014 10:30:41 AM
Next Generation Researchers Recognized In The AbbVie (ABBV) Student Poster Awards 11/13/2014 11:38:56 AM
AbbVie (ABBV)'s Leadership In Immunology Featured At 2014 American College of Rheumatology Annual Meeting With New Data On Investigational Medicines And HUMIRA® (adalimumab) 11/13/2014 10:01:21 AM
AbbVie (ABBV) Uses Patents To Ambush Gilead Sciences, Inc. (GILD) 11/13/2014 6:40:25 AM
12345678910...